105 related articles for article (PubMed ID: 1868680)
1. Measuring compliance in methadone maintenance patients: use of a pharmacologic indicator to "estimate" methadone plasma levels.
Wolff K; Hay A; Raistrick D; Calvert R; Feely M
Clin Pharmacol Ther; 1991 Aug; 50(2):199-207. PubMed ID: 1868680
[TBL] [Abstract][Full Text] [Related]
2. Use of 'very low-dose phenobarbital' to investigate compliance in patients on reducing doses of methadone (detoxification).
Wolff K; Hay AA; Raistrick D; Feely M
J Subst Abuse Treat; 1993; 10(5):453-8. PubMed ID: 8246320
[TBL] [Abstract][Full Text] [Related]
3. Plasma methadone measurements and their role in methadone detoxification programs.
Wolff K; Hay AW; Raistrick D
Clin Chem; 1992 Mar; 38(3):420-5. PubMed ID: 1547564
[TBL] [Abstract][Full Text] [Related]
4. A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients.
Margolin A; Kantak K; Copenhaver M; Avants SK
J Addict Dis; 2003; 22(2):49-61. PubMed ID: 12703668
[TBL] [Abstract][Full Text] [Related]
5. Limit setting on drug abuse in methadone maintenance patients.
McCarthy JJ; Borders OT
Am J Psychiatry; 1985 Dec; 142(12):1419-23. PubMed ID: 4073304
[TBL] [Abstract][Full Text] [Related]
6. Dose, Plasma Level, and Treatment Outcome Among Methadone Patients in Shanghai, China.
Jiang H; Hillhouse M; Du J; Pan S; Alfonso A; Wang J; Zhou Z; Yuan W; Ling W; Zhao M
Neurosci Bull; 2016 Dec; 32(6):538-544. PubMed ID: 27612968
[TBL] [Abstract][Full Text] [Related]
7. Methadone concentrations in plasma and their relationship to drug dosage.
Wolff K; Sanderson M; Hay AW; Raistrick D
Clin Chem; 1991 Feb; 37(2):205-9. PubMed ID: 1993325
[TBL] [Abstract][Full Text] [Related]
8. The use of plasma levels to optimize methadone maintenance treatment.
Loimer N; Schmid R
Drug Alcohol Depend; 1992 Aug; 30(3):241-6. PubMed ID: 1396105
[TBL] [Abstract][Full Text] [Related]
9. Correlation between high methadone doses and methadone serum levels in methadone maintenance treatment (MMT) patients.
Adelson M; Peles E; Bodner G; Kreek MJ
J Addict Dis; 2007; 26(1):15-26. PubMed ID: 17439864
[TBL] [Abstract][Full Text] [Related]
10. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
[TBL] [Abstract][Full Text] [Related]
11. Methadone maintenance. Does dose determine differences in outcome?
Blaney T; Craig RJ
J Subst Abuse Treat; 1999 Apr; 16(3):221-8. PubMed ID: 10194739
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z
Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
[TBL] [Abstract][Full Text] [Related]
13. Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment.
Meini M; Moncini M; Daini L; Giarratana T; Scaramelli D; Chericoni S; Stefanelli F; Rucci P
Eur J Pharmacol; 2015 Aug; 760():1-6. PubMed ID: 25891369
[TBL] [Abstract][Full Text] [Related]
14. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
[TBL] [Abstract][Full Text] [Related]
15. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily.
Pullar T; Birtwell AJ; Wiles PG; Hay A; Feely MP
Clin Pharmacol Ther; 1988 Nov; 44(5):540-5. PubMed ID: 3180635
[TBL] [Abstract][Full Text] [Related]
16. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.
Johnson RE; Chutuape MA; Strain EC; Walsh SL; Stitzer ML; Bigelow GE
N Engl J Med; 2000 Nov; 343(18):1290-7. PubMed ID: 11058673
[TBL] [Abstract][Full Text] [Related]
17. Initial evaluation of low-dose phenobarbital as an indicator of compliance with antimalarial drug treatment.
Karbwang J; Fungladda W; Pickard CE; Shires S; Hay A; Feely M
Bull World Health Organ; 1998; 76 Suppl 1(Suppl 1):67-73. PubMed ID: 9763725
[TBL] [Abstract][Full Text] [Related]
18. Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue.
McElrath K; Joseph H
Subst Use Misuse; 2018 Jan; 53(2):177-180. PubMed ID: 29220615
[TBL] [Abstract][Full Text] [Related]
19. Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment.
Hiltunen AJ; Beck O; Hjemdahl P; Liljeberg P; Almström U; Brodin K; von Wachenfeldt J; Borg S
Psychopharmacology (Berl); 1999 Apr; 143(4):385-93. PubMed ID: 10367556
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of an implementation of methadone maintenance treatment in China.
Marienfeld C; Liu P; Wang X; Schottenfeld R; Zhou W; Chawarski MC
Drug Alcohol Depend; 2015 Dec; 157():60-7. PubMed ID: 26601934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
